Compare WKC & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WKC | BBNX |
|---|---|---|
| Founded | 1984 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | 2025 |
| Metric | WKC | BBNX |
|---|---|---|
| Price | $24.39 | $29.65 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 11 |
| Target Price | ★ $28.75 | $28.09 |
| AVG Volume (30 Days) | ★ 743.5K | 672.2K |
| Earning Date | 10-23-2025 | 10-28-2025 |
| Dividend Yield | ★ 3.30% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $37,648,100,000.00 | $88,570,000.00 |
| Revenue This Year | N/A | $52.13 |
| Revenue Next Year | $1.13 | $36.16 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $22.71 | $8.89 |
| 52 Week High | $31.54 | $32.71 |
| Indicator | WKC | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 53.50 | 56.71 |
| Support Level | $23.78 | $28.00 |
| Resistance Level | $24.36 | $30.50 |
| Average True Range (ATR) | 0.54 | 1.82 |
| MACD | 0.15 | -0.26 |
| Stochastic Oscillator | 81.42 | 38.33 |
World Kinect Corp is an energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers. It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. The company operates in three reportable segments consisting of aviation, land, and marine. The company earns the majority of its revenue from the Aviation segment.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.